Sichuan Biokin Pharmaceutical Co.,Ltd. (SHA:688506)

SHA:688506 Revenue

Sichuan Biokin Pharmaceutical had revenue of 1.91B CNY in the quarter ending September 30, 2026, with 0.63% growth. This brings the company's total for the last twelve months to 2.55B, up 14.47% year-over-year. In the year 2025, Sichuan Biokin Pharmaceutical had annual revenue of 2.52B, down -56.72%. That makes Sichuan Biokin Pharmaceutical the 12,877th largest company in the world by revenue and 2,254th in China.

• Revenue (ttm): 2.55B
• Revenue Growth: +14.47%
• P/S Ratio: 39.55
• Revenue / Employee: 742.02K
• Employees: 3,434
• Market Cap: 100.77B

Revenue Chart

Chart

Chart

Revenue by Geography

Chart

• Overseas 2.12B 84.8%
• China 380.08M 15.2%

Fiscal year ended Dec 31, 2025 See the full SHA:688506 breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	2.52B	-3.30B	-56.72%
Dec 31, 2024	5.82B	5.26B	936.31%
Dec 31, 2023	561.87M	-141.41M	-20.11%
Dec 31, 2022	703.28M	-93.45M	-11.73%
Dec 31, 2021	796.73M	-215.98M	-21.33%

Data Source: S&P Global Market Intelligence Last updated: Oct 30, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Oct 31, 2026

Data Sources Report a data error